slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 38,641-38,670
Pages 10,126
Rows per page 30
Component
38,641-38,670 of 303,780
13
The slide uses a dark sidebar for product specs and a white main area for clinical data visualization.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 2 hits
14
The slide uses a split-layout with a dark sidebar for key facts and a white main area for clinical data visualization.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 2 hits
20
The slide uses a split-layout: left side defines the condition and global burden, right side details the 'huge need for development' using a vertical timeline-like list.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 2 hits
23
The slide highlights efficacy in cognitive endpoints for a specific patient population (DPNP).ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 2 hits
28
Includes a sidebar summary and a clinical trial design overview.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 2 hits
32
Includes a summary table on the left and clinical trial data/roadmap on the right.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 2 hits
33
The table highlights DMX-1002's unique profile compared to withdrawal support and maintenance therapies.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 2 hits
03
ATAI | Investor Presentation Deck | 41 slidesATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations Beat · Situation & Context2 hits
18
ATAI | Investor Presentation Deck | 41 slidesATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done2 hits
23
ATAI | Investor Presentation Deck | 41 slidesATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done2 hits
27
ATAI | Investor Presentation Deck | 41 slidesATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done2 hits
33
ATAI | Investor Presentation Deck | 41 slidesATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done2 hits
37
ATAI | Investor Presentation Deck | 41 slidesATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done2 hits
04
Athira Pharma | Results Presentation Deck | 11 slidesAthira Pharma | Results Presentation Deck | 11 slides · Athira Pharma
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done2 hits
05
The chart shows a significant p-value of 0.018 for NfL reduction. The study design is noted as randomized, double-blind, placebo-controlled, and parallel-group.Athira Pharma | Results Presentation Deck | 11 slides · Athira Pharma
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done2 hits
06
The slide uses a process-flow style table to outline the clinical trial structure.Athira Pharma | Results Presentation Deck | 11 slides · Athira Pharma
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done2 hits
07
The slide uses a list format to show progress/process steps.Athira Pharma | Results Presentation Deck | 11 slides · Athira Pharma
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done2 hits
08
The framework is a clinical trial decision matrix based on ADAS-Cog11 and ADCS-ADL23 scores.Athira Pharma | Results Presentation Deck | 11 slides · Athira Pharma
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done2 hits
09
Athira Pharma | Results Presentation Deck | 11 slidesAthira Pharma | Results Presentation Deck | 11 slides · Athira Pharma
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done2 hits
10
The table uses checkmarks to indicate the strength of effect for different GABA-A subtypes (alpha 1, 2, 3, 5).Avenue Therapeutics | IPO Presentation Deck | 30 slides · Avenue Therapeutics
Regulatory filing Investment bank Beat · Solution2 hits
13
Uses a Venn-like containment diagram to show sub-segments of a larger market.Avenue Therapeutics | IPO Presentation Deck | 30 slides · Avenue Therapeutics
Regulatory filing Investment bank Beat · Market SizeLoop · Cost Of Inaction2 hits
16
The slide highlights the therapeutic window of BAER-101 by showing efficacy in the punished model without significant impairment in the un-punished model.Avenue Therapeutics | IPO Presentation Deck | 30 slides · Avenue Therapeutics
Regulatory filing Investment bank Beat · Product2 hits
27
The slide uses a grid-based layout to categorize metrics into three distinct pillars: Digital Adoption, Client Engagement, and Digital Volumes.Bank of America | Results Presentation Deck | 36 slides · Bank of America
Conference presentation Investor relations Beat · KPI Overview2 hits
03
BenevolentAI | Investor Presentation Deck | 46 slidesBenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 2 hits
14
The slide uses a split-layout with a dark sidebar for partnership specifics and a light main area for strategic benefits.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 2 hits
39
The slide uses a flowchart to illustrate the adaptive clinical trial design.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 2 hits
40
The slide outlines a clinical trial process flow with specific durations and patient ratios.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 2 hits
01
The brain graphic is a stylized circuit board, representing the intersection of neuroscience and technology.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 2 hits
22
The slide displays a snippet of the LSAS questionnaire, showing the scoring criteria for 'Fear or Anxiety' and 'Avoidance' and providing examples of the 24 items.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Solution2 hits
39
Bionomics | Investor Presentation Deck | 59 slidesBionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 2 hits